Results 1 to 10 of about 99,760 (303)

The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection [PDF]

Mental Health Clinician, 2021
Introduction: Dosing recommendations for paliperidone long-acting injectable antipsychotic (LAIA) do not include oral antipsychotic (OAP) overlap; however, OAPs are often given concurrently despite limited evidence describing both the risks and benefits ...
Trevor A. Stump, PharmD, BCPP, Leigh Anne Nelson, PharmD, BCPP, Yifei Liu, BS Pharm, PhD, Carrie R. Kriz, MS, Courtney A. Iuppa, PharmD, BCPP, Lauren A. Diefenderfer, PharmD, BCPP, Shelby E. Lang, PharmD, BCPP, Ellie S. R. Elliot, PharmD, BCPP, Roger W. Sommi, PharmD, BCPP, FCCP   +8 more
doaj   +1 more source

The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study

Frontiers in Medicine, 2021
Objectives: To investigate the impact of portal vein thrombosis (PVT) on cirrhosis decompensation and survival of cirrhosis.Methods: In this retrospective observational study between January 2012 and August 2020, 117 patients with cirrhotic PVT and 125 ...
Zhiji Chen, Tao Ran, Haiyan Cao, Feng Xu, Zhi-hang Zhou, Song He   +5 more
doaj   +1 more source

Hepatic Venous Pressure Gradient Predicts Further Decompensation in Cirrhosis Patients with Acute Esophageal Variceal Bleeding

Diagnostics, 2023
Background: The role of hepatic venous pressure gradient (HVPG) in predicting further decompensation in cirrhosis patients with acute variceal bleeding (AVB) is not known.
Manas Vaishnav, Sagnik Biswas, Abhinav Anand, Piyush Pathak, Shekhar Swaroop, Arnav Aggarwal, Umang Arora, Anshuman Elhence, Shivanand Gamanagatti, Amit Goel, Ramesh Kumar, Shalimar   +11 more
doaj   +1 more source

Analysis of pathogenetic manifestation of decompensated intestinal dysbacteriosis in cats

RUDN Journal of Agronomy and Animal Industries, 2023
Despite the creation of more and more new generations of antibacterial agents, the correction of intestinal dysbiosis in animals currently remains one of the most complex and urgent problems in clinical veterinary medicine.
Evgeny V. Kulikov, Nikolai V. Babichev, Alena I. Telezhenkova, Nikolai S. Bugrov, Pavel A. Rudenko   +4 more
doaj   +1 more source

Predicting Decompensation Risk in Intensive Care Unit Patients Using Machine Learning

Algorithms, 2023
Patients in Intensive Care Units (ICU) face the threat of decompensation, a rapid decline in health associated with a high risk of death. This study focuses on creating and evaluating machine learning (ML) models to predict decompensation risk in ICU ...
Nosa Aikodon, Sandra Ortega-Martorell, Ivan Olier   +2 more
doaj   +1 more source

Practical aspects of vericiguat therapy in patients with heart failure with reduced ejection fraction. Expert council resolution

Российский кардиологический журнал, 2023
The objective of this advisory board meeting was to discuss the place of vericiguat in the treatment algorithm for heart failure with reduced ejection fraction and the necessary requirements for its successful application in clinical practice.
S. A. Boytsov, S. N. Tereshchenko, S. V. Villevalde, A. S. Galyavich, A. A. Garganeeva, M. G. Glezer, D. V. Duplyakov, I. V. Zhirov, Zh. D. Kobalava, Yu. M. Lopatin, S. V. Nedogoda, E. I. Tarlovskaya   +11 more
doaj   +1 more source

Benchmarking machine learning models on multi-centre eICU critical care dataset [PDF]

, 2020
Progress of machine learning in critical care has been difficult to track, in part due to absence of public benchmarks. Other fields of research (such as computer vision and natural language processing) have established various competitions and public ...
Balaraman, Vevake, Osmani, Venet, Sheikhalishahi, Seyedmostafa   +2 more
core   +3 more sources

European Consensus on use of diuretics in chronic heart failure 2019

Медицинский совет, 2020
The article presents the consensus materials of the European Society of Cardiology on the use of diuretics in chronic heart failure (CHF). Diuretics represent an important class of drugs for the treatment of heart failure from the perspective of evidence
M. V. Leonova
doaj   +1 more source

The SCottish Alcoholic Liver disease Evaluation: a population-level matched cohort study of hospital-based costs, 1991-2011 [PDF]

, 2016
Studies assessing the costs of alcoholic liver disease are lacking. We aimed to calculate the costs of hospitalisations before and after diagnosis compared to population controls matched by age, sex and socio-economic deprivation.
A Bagust, A Sjölander, AN Aljoudeh, Andrew Briggs, AV Shinde, B Gao, B Hudson, Claudia Geue, Gerry McCartney, Grace Antony, H Cortez-Pinto, J Lloyd-Evans, J Rhem, James Lewsey, Janet Bouttell, JF Boylan, Lesley Graham, M Blachier, M Heydtmann, Mathis Heydtmann, Nick Sheron, R Jinjuvadia, R Williams, S Liangpunsakul, S Ratib, S Ryder, Sharon Hutchinson, T Deleuran, T McDonnell, TD Sandahl, Vincent Wong   +30 more
core   +7 more sources

Early indication of decompensated heart failure in patients on home-telemonitoring: a comparison of prediction algorithms based on daily weight and noninvasive transthoracic bio-impedance [PDF]

, 2016
Background: Heart Failure (HF) is a common reason for hospitalization. Admissions might be prevented by early detection of and intervention for decompensation. Conventionally, changes in weight, a possible measure of fluid accumulation, have been used to
Amft, Oliver, Bonomi, Alberto G., Cleland, John G.F., Cuba Gyllensten, Illapha, Goode, Kevin M., Habetha, Joerg, Reiter, Harald   +6 more
core   +2 more sources